W. C. Aird, Endothelium in health and disease, Pharmacol Rep, vol.60, p.139, 2008.

J. S. Pober, W. Min, and J. R. Bradley, Mechanisms of endothelial dysfunction, injury, and death, Annu Rev Pathol, vol.4, p.71, 2009.

R. B. Colvin, Antibody-mediated renal allograft rejection: diagnosis and pathogenesis, J Am Soc Nephrol, vol.18, p.1046, 2007.

P. Libby and J. S. Pober, Chronic rejection, Immunity, vol.14, p.387, 2001.

F. H. Bach, C. Ferran, P. Hechenleitner, W. Mark, N. Koyamada et al., Accommodation of vascularized xenografts: expression of ''protective genes'' by donor endothelial cells in a host Th2 cytokine environment, Nat Med, vol.3, p.196, 1997.

S. Kinlay, P. Libby, and P. Ganz, Endothelial function and coronary artery disease, Curr Opin Lipidol, vol.12, p.383, 2001.

J. S. Pober and R. S. Cotran, The role of endothelial cells in inflammation, Transplantation, vol.50, p.537, 1990.

J. S. Pober and W. C. Sessa, Evolving functions of endothelial cells in inflammation, Nat Rev Immunol, vol.7, p.803, 2007.

D. M. Briscoe and M. H. Sayegh, A rendezvous before rejection: where do T cells meet transplant antigens, Nat Med, vol.8, p.220, 2002.

S. Coupel, A. Moreau, M. Hamidou, V. Horejsi, J. P. Soulillou et al., Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation, Blood, vol.109, p.2806, 2007.

G. P. Alexandre, J. P. Squifflet, M. De-bruyere, D. Latinne, R. Reding et al., Present experiences in a series of 26 ABO-incompatible living donor renal allografts, Transplant Proc, vol.19, p.4538, 1987.

F. H. Bach, M. A. Turman, G. M. Vercellotti, J. L. Platt, and A. P. Dalmasso, Accommodation: a working paradigm for progressing toward clinical discordant xenografting, Transplant Proc, vol.23, p.205, 1991.

M. P. Soares, Y. Lin, J. Anrather, E. Csizmadia, K. Takigami et al., Expression of heme oxygenase-1 can determine cardiac xenograft survival, Nat Med, vol.4, p.1073, 1998.

A. D. Salama, A. Delikouras, C. D. Pusey, H. T. Cook, G. Bhangal et al., Transplant accommodation in highly sensitized patients: a potential role for Bcl-xL and alloantibody, Am J Transplant, vol.1, p.260, 2001.

W. D. Park, J. P. Grande, D. Ninova, K. A. Nath, J. L. Platt et al., Accommodation in ABO-incompatible kidney allografts, a novel mechanism of self-protection against antibody-mediated injury, Am J Transplant, vol.3, p.952, 2003.

C. E. Murry, R. B. Jennings, and K. A. Reimer, Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium, Circulation, vol.74, p.1124, 1986.

S. Sanada, I. Komuro, and M. Kitakaze, Pathophysiology of myocardial reperfusion injury: preconditioning, postconditioning, and translational aspects of protective measures, Am J Physiol Heart Circ Physiol, vol.301, p.1723, 2011.

F. H. Bach, W. W. Hancock, and C. Ferran, Protective genes expressed in endothelial cells: a regulatory response to injury, Immunol Today, vol.18, p.483, 1997.

A. Karsan, E. Yee, K. Kaushansky, and J. M. Harlan, Cloning of human Bcl-2 homologue: inflammatory cytokines induce human A1 in cultured endothelial cells, Blood, vol.87, p.3089, 1996.

D. L. Vaux, S. Cory, and J. M. Adams, Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells, Nature, vol.335, p.440, 1988.

A. Z. Badrichani, D. M. Stroka, G. Bilbao, D. T. Curiel, F. H. Bach et al., Bcl-2 and Bcl-XL serve an anti-inflammatory function in endothelial cells through inhibition of NF-kappaB, J Clin Invest, vol.103, p.543, 1999.

B. Longoni, E. Boschi, G. C. Demontis, G. M. Ratto, and F. Mosca, Apoptosis and adaptive responses to oxidative stress in human endothelial cells exposed to cyclosporin A correlate with BCL-2 expression levels, FASEB J, vol.15, p.731, 2001.

D. M. Stroka, A. Z. Badrichani, F. H. Bach, and C. Ferran, Overexpression of A1, an NFkappaB-inducible anti-apoptotic bcl gene, inhibits endothelial cell activation, Blood, vol.93, p.3803, 1999.

A. B. Werner, E. De-vries, S. W. Tait, I. Bontjer, and J. Borst, Bcl-2 family member Bfl-1/ A1 sequesters truncated bid to inhibit is collaboration with pro-apoptotic Bak or Bax, J Biol Chem, vol.277, p.22781, 2002.

A. W. Opipari, M. S. Boguski, and V. M. Dixit, The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein, J Biol Chem, vol.265, p.14705, 1990.

E. W. Harhaj and V. M. Dixit, Deubiquitinases in the regulation of NF-kappaB signaling, Cell Res, vol.21, p.22, 2011.

C. Ferran, D. M. Stroka, A. Z. Badrichani, J. T. Cooper, C. J. Wrighton et al., A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis, Blood, vol.91, p.2249, 1998.

S. T. Grey, M. B. Arvelo, W. Hasenkamp, F. H. Bach, and C. Ferran, A20 inhibits cytokineinduced apoptosis and nuclear factor kappaB-dependent gene activation in islets, J Exp Med, vol.190, p.1135, 1999.

N. Shembade, K. Parvatiyar, N. S. Harhaj, and E. W. Harhaj, The ubiquitin-editing enzyme A20 requires RNF11 to downregulate NF-kappaB signalling, EMBO J, vol.28, p.513, 2009.

I. E. Wertz, K. M. O'rourke, H. Zhou, M. Eby, L. Aravind et al., Deubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling, Nature, vol.430, p.694, 2004.

E. C. Lacasse, S. Baird, R. G. Korneluk, and A. E. Mackenzie, The inhibitors of apoptosis (IAPs) and their emerging role in cancer, Oncogene, vol.17, p.3247, 1998.

G. Ambrosini, C. Adida, and D. C. Altieri, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat Med, vol.3, p.917, 1997.

L. K. Miller, An exegesis of IAPs: salvation and surprises from BIR motifs, Trends Cell Biol, vol.9, p.323, 1999.

D. S. O'connor, J. S. Schechner, C. Adida, M. Mesri, A. L. Rothermel et al., Control of apoptosis during angiogenesis by survivin expression in endothelial cells, Am J Pathol, vol.156, p.393, 2000.

K. Mahboubi, F. Li, J. Plescia, N. C. Kirkiles-smith, M. Mesri et al., Interleukin-11 up-regulates survivin expression in endothelial cells through a signal transducer and activator of transcription-3 pathway, Lab Invest, vol.81, p.327, 2001.

N. C. Kirkiles-smith, K. Mahboubi, J. Plescia, J. M. Mcniff, J. Karras et al., IL-11 protects human microvascular endothelium from alloinjury in vivo by induction of survivin expression, J Immunol, vol.172, p.1391, 2004.

D. Santini, A. Abbate, S. Scarpa, F. Vasaturo, G. G. Biondi-zoccai et al., Surviving acute myocardial infarction: survivin expression in viable cardiomyocytes after infarction, J Clin Pathol, vol.57, p.1321, 2004.

A. Abbate, S. Scarpa, D. Santini, J. Palleiro, F. Vasaturo et al., Myocardial expression of survivin, an apoptosis inhibitor, in aging and heart failure. An experimental study in the spontaneously hypertensive rat, Int J Cardiol, vol.111, p.371, 2006.

H. F. Simosa, G. Wang, X. Sui, T. Peterson, V. Narra et al., Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype, J Vasc Surg, vol.41, p.682, 2005.

S. R. Vulapalli, Z. Chen, B. H. Chua, T. Wang, and C. S. Liang, Cardioselective overexpression of HO-1 prevents I/R-induced cardiac dysfunction and apoptosis, Am J Physiol Heart Circ Physiol, vol.283, p.688, 2002.

L. E. Otterbein, B. S. Zuckerbraun, M. Haga, F. Liu, R. Song et al., Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury, Nat Med, vol.9, p.183, 2003.

K. Sato, J. Balla, L. Otterbein, R. N. Smith, S. Brouard et al., Carbon monoxide generated by heme oxygenase-1 suppresses the rejection of mouse-to-rat cardiac transplants, J Immunol, vol.166, p.4185, 2001.

L. E. Otterbein, S. L. Otterbein, E. Ifedigbo, F. Liu, D. E. Morse et al., MKK3 mitogen-activated protein kinase pathway mediates carbon monoxideinduced protection against oxidant-induced lung injury, Am J Pathol, vol.163, p.2555, 2003.

X. M. Wang, H. P. Kim, K. Nakahira, S. W. Ryter, and A. M. Choi, The heme oxygenase-1/ carbon monoxide pathway suppresses TLR4 signaling by regulating the interaction of TLR4 with caveolin-1, J Immunol, vol.182, p.3809, 2009.

R. Sen and D. Baltimore, Multiple nuclear factors interact with the immunoglobulin enhancer sequences, Cell, vol.46, p.705, 1986.

Q. Li and I. M. Verma, NF-kappaB regulation in the immune system, Nat Rev Immunol, vol.2, p.725, 2002.

S. Vallabhapurapu and M. Karin, Regulation and function of NF-kappaB transcription factors in the immune system, Annu Rev Immunol, vol.27, p.693, 2009.

M. Karin and Y. Ben-neriah, Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity, Annu Rev Immunol, vol.18, p.621, 2000.

L. A. Madge and J. S. Pober, A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFkappaB in human endothelial cells, J Biol Chem, vol.275, p.15458, 2000.

I. Kim, H. G. Kim, J. N. So, J. H. Kim, H. J. Kwak et al., Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3 0 -kinase/Akt signal transduction pathway, Circ Res, vol.86, p.24, 2000.

C. Rommel, M. Camps, and H. Ji, PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond?, Nat Rev Immunol, vol.7, p.191, 2007.

V. Stambolic, A. Suzuki, J. L. De-la-pompa, G. M. Brothers, C. Mirtsos et al., Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN, Cell, vol.95, p.29, 1998.

H. Kishimoto, K. Hamada, M. Saunders, S. Backman, T. Sasaki et al., Physiological functions of Pten in mouse tissues, Cell Struct Funct, vol.28, p.11, 2003.

S. Dimmeler, I. Fleming, B. Fisslthaler, C. Hermann, R. Busse et al., Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation, Nature, vol.399, p.601, 1999.

T. Matsui, J. Tao, F. Del-monte, K. H. Lee, L. Li et al., Akt activation preserves cardiac function and prevents injury after transient cardiac ischemia in vivo, Circulation, vol.104, p.330, 2001.

A. Yamaguchi, M. Tamatani, H. Matsuzaki, K. Namikawa, H. Kiyama et al., Akt activation protects hippocampal neurons from apoptosis by inhibiting transcriptional activity of p53, J Biol Chem, vol.276, p.5256, 2001.

S. Dimmeler, B. Assmus, C. Hermann, J. Haendeler, and A. M. Zeiher, Fluid shear stress stimulates phosphorylation of Akt in human endothelial cells: involvement in suppression of apoptosis, Circ Res, vol.83, p.334, 1998.

Y. Zhang, T. S. Park, and J. M. Gidday, Hypoxic preconditioning protects human brain endothelium from ischemic apoptosis by Akt-dependent survivin activation, Am J Physiol Heart Circ Physiol, vol.292, p.2573, 2007.

J. F. Grehan, B. K. Levay-young, J. L. Fogelson, V. Francois-bongarcon, B. A. Benson et al., IL-4 and IL-13 induce protection of porcine endothelial cells from killing by human complement and from apoptosis through activation of a phosphatidylinositide 3-kinase/Akt pathway, J Immunol, vol.175, 1903.

S. M. Black, B. A. Benson, D. Idossa, G. M. Vercellotti, and A. P. Dalmasso, Protection of porcine endothelial cells against apoptosis with interleukin-4, Xenotransplantation, vol.18, p.343, 2011.

Y. Jin and E. Reed, Ligation of class I molecules on endothelial cells stimulates phosphorylation of focal adhesion kinase at TYR-576/577 and triggers the PI3K/AKT signaling cascade, Hum Immunol, vol.63, p.52, 2002.

S. Coupel, F. Leboeuf, G. Boulday, J. P. Soulillou, and B. Charreau, RhoA activation mediates phosphatidylinositol 3-kinase-dependent proliferation of human vascular endothelial cells: an alloimmune mechanism of chronic allograft nephropathy, J Am Soc Nephrol, vol.15, p.2429, 2004.

X. Zhang, E. Rozengurt, and E. F. Reed, HLA class I molecules partner with integrin beta4 to stimulate endothelial cell proliferation and migration, Sci Signal, vol.3, p.85, 2010.

Y. P. Jin, M. C. Fishbein, J. W. Said, P. T. Jindra, R. Rajalingam et al., Anti-HLA class I antibody-mediated activation of the PI3K/Akt signaling pathway and induction of Bcl-2 and Bcl-xL expression in endothelial cells, Hum Immunol, vol.65, p.291, 2004.

L. Chang and M. Karin, Mammalian MAP kinase signalling cascades, Nature, vol.410, p.37, 2001.

B. A. Rose, T. Force, and Y. Wang, Mitogen-activated protein kinase signaling in the heart: angels versus demons in a heart-breaking tale, Physiol Rev, vol.90, p.1507, 2010.

A. M. Domina, J. A. Vrana, M. A. Gregory, S. R. Hann, and R. W. Craig, MCL1 is phosphorylated in the PEST region and stabilized upon ERK activation in viable cells, and at additional sites with cytotoxic okadaic acid or taxol, Oncogene, vol.23, p.5301, 2004.

A. Das, F. N. Salloum, L. Xi, Y. J. Rao, and R. C. Kukreja, ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice, Am J Physiol Heart Circ Physiol, vol.296, p.1236, 2009.

S. Dhingra, A. K. Sharma, R. C. Arora, J. Slezak, and P. K. Singal, IL-10 attenuates TNFalpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis, Cardiovasc Res, vol.82, p.59, 2009.

K. Sabapathy, T. Kallunki, J. P. David, I. Graef, M. Karin et al., C-Jun NH2-terminal kinase (JNK)1 and JNK2 have similar and stage-dependent roles in regulating T cell apoptosis and proliferation, J Exp Med, vol.193, p.317, 2001.

C. Hull, G. Mclean, F. Wong, P. J. Duriez, and A. Karsan, Lipopolysaccharide signals an endothelial apoptosis pathway through TNF receptor-associated factor 6-mediated activation of c-Jun NH2-terminal kinase, J Immunol, vol.169, p.2611, 2002.

C. Bubici, S. Papa, C. G. Pham, F. Zazzeroni, and G. Franzoso, The NF-kappaB-mediated control of ROS and JNK signaling, Histol Histopathol, vol.21, p.69, 2006.

U. Resch, Y. M. Schichl, G. Winsauer, R. Gudi, K. Prasad et al., Siva1 is a XIAP-interacting protein that balances NFkappaB and JNK signalling to promote apoptosis, J Cell Sci, vol.122, p.2651, 2009.

C. Steenbergen, The role of p38 mitogen-activated protein kinase in myocardial ischemia/reperfusion injury; relationship to ischemic preconditioning, Basic Res Cardiol, vol.97, p.276, 2002.

H. Zhou, M. Zheng, J. Chen, C. Xie, A. R. Kolatkar et al., Determinants that control the specific interactions between TAB1 and p38alpha, Mol Cell Biol, vol.26, p.3824, 2006.

B. M. Jehn, W. Bielke, W. S. Pear, and B. A. Osborne, Cutting edge: protective effects of notch-1 on TCR-induced apoptosis, J Immunol, vol.162, p.635, 1999.

J. F. De-celis and A. Garcia-bellido, Roles of the Notch gene in Drosophila wing morphogenesis, Mech Dev, vol.46, p.109, 1994.

S. Artavanis-tsakonas, M. D. Rand, and R. J. Lake, Notch signaling: cell fate control and signal integration in development, Science, vol.284, p.770, 1999.

H. Uyttendaele, G. Marazzi, G. Wu, Q. Yan, D. Sassoon et al., Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene, Development, vol.122, p.2251, 1996.

C. Mailhos, U. Modlich, J. Lewis, A. Harris, and R. Bicknell, Ish-Horowicz D. Delta4, an endothelial specific notch ligand expressed at sites of physiological and tumor angiogenesis, Differentiation, vol.69, p.135, 2001.

L. T. Krebs, Y. Xue, C. R. Norton, J. R. Shutter, M. Maguire et al., Notch signaling is essential for vascular morphogenesis in mice, Genes Dev, vol.14, p.1343, 2000.

G. Van-tetering and M. Vooijs, Proteolytic cleavage of Notch: ''HIT and RUN, Curr Mol Med, vol.11, p.255, 2011.

O. Nakagawa, D. G. Mcfadden, M. Nakagawa, H. Yanagisawa, T. Hu et al., Members of the HRT family of basic helix-loop-helix proteins act as transcriptional repressors downstream of Notch signaling, Proc Natl Acad Sci, vol.97, p.13655, 2000.

T. Iso, L. Kedes, and Y. Hamamori, HES and HERP families: multiple effectors of the Notch signaling pathway, J Cell Physiol, vol.194, p.237, 2003.

K. Piggott, J. Deng, K. Warrington, B. Younge, J. T. Kubo et al., Blocking the NOTCH pathway inhibits vascular inflammation in large-vessel vasculitis, Circulation, vol.123, p.309, 2011.

L. Bugeon, L. M. Gardner, A. Rose, M. Gentle, and M. J. Dallman, Cutting edge: Notch signaling induces a distinct cytokine profile in dendritic cells that supports T cell-mediated regulation and IL-2-dependent IL-17 production, J Immunol, vol.181, p.8189, 2008.

T. Quillard, J. Devalliere, S. Coupel, and B. Charreau, Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction, Biochem Pharmacol, vol.80, p.2032, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00637150

T. Quillard, S. Coupel, F. Coulon, J. Fitau, M. Chatelais et al., Impaired Notch4 activity elicits endothelial cell activation and apoptosis: implication for transplant arteriosclerosis, Arterioscler Thromb Vasc Biol, vol.28, p.2258, 2008.

F. Mackenzie, P. Duriez, F. Wong, M. Noseda, and A. Karsan, Notch4 inhibits endothelial apoptosis via RBP-Jkappa-dependent and -independent pathways, J Biol Chem, vol.279, p.11657, 2004.

T. Quillard, J. Devalliere, M. Chatelais, F. Coulon, C. Seveno et al., Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule survivin, PLoS One, vol.4, p.8244, 2009.

W. C. Aird, Sepsis and coagulation, Crit Care Clin, vol.21, p.417, 2005.

C. T. Esmon, Inflammation and the activated protein C anticoagulant pathway, Semin Thromb Hemost, vol.32, issue.1, p.49, 2006.

P. F. Laterre, W. L. Macias, J. Janes, M. D. Williams, D. R. Nelson et al., Influence of enrollment sequence effect on observed outcomes in the ADDRESS and PROWESS studies of drotrecogin alfa (activated) in patients with severe sepsis, Crit Care, vol.12, p.117, 2008.

L. O. Mosnier, B. V. Zlokovic, and J. H. Griffin, The cytoprotective protein C pathway, Blood, vol.109, p.3161, 2007.

K. Fukudome and C. T. Esmon, Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor, J Biol Chem, vol.269, p.26486, 1994.

C. T. Esmon, The endothelial protein C receptor, Curr Opin Hematol, vol.13, p.382, 2006.

D. E. Joyce, L. Gelbert, A. Ciaccia, B. Dehoff, and B. W. Grinnell, Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis, J Biol Chem, vol.276, p.11199, 2001.

M. Riewald, R. J. Petrovan, A. Donner, B. M. Mueller, and W. Ruf, Activation of endothelial cell protease activated receptor 1 by the protein C pathway, Science, vol.296, p.1880, 2002.

T. Cheng, D. Liu, J. H. Griffin, J. A. Fernandez, F. Castellino et al., Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective, Nat Med, vol.9, p.338, 2003.

M. Uchiba, K. Okajima, Y. Oike, Y. Ito, K. Fukudome et al., Activated protein C induces endothelial cell proliferation by mitogen-activated protein kinase activation in vitro and angiogenesis in vivo, Circ Res, vol.95, p.34, 2004.

M. Riewald and W. Ruf, Protease-activated receptor-1 signaling by activated protein C in cytokine-perturbed endothelial cells is distinct from thrombin signaling, J Biol Chem, vol.280, 2005.

C. Guitton, A. Cottereau, N. Gerard, T. Quillard, A. Chauveau et al., Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-kappaB, and ERK1/2 MAP kinases, Am J Physiol Cell Physiol, vol.300, p.833, 2011.

V. Horejsi, W. Zhang, and B. Schraven, Transmembrane adaptor proteins: organizers of immunoreceptor signalling, Nat Rev Immunol, vol.4, p.603, 2004.

T. Pawson, Dynamic control of signaling by modular adaptor proteins, Curr Opin Cell Biol, vol.19, p.112, 2007.